scholarly journals Breast cancer treatment patterns by age and time since last pregnancy in the Carolina Breast Cancer Study-Phase III

Author(s):  
Sanah N. Vohra ◽  
Katherine E. Reeder-Hayes ◽  
Hazel B. Nichols ◽  
Marc Emerson ◽  
Michael I. Love ◽  
...  

Abstract PurposeTo describe breast cancer treatment patterns among premenopausal women by age and time since last pregnancy. MethodsData were analyzed from 1,179 women diagnosed with premenopausal breast cancer in the Carolina Breast Cancer Study. Of these, 160 had a recent pregnancy (within 5 years of cancer diagnosis). Relative frequency differences (RFDs) and 95% confidence intervals (CIs) were used to compare cancer stage, treatment modality received, treatment initiation delay (>30 days), and prolonged treatment duration (>2 to >8 months depending on the treatment received) by age and recency of pregnancy. ResultsRecently postpartum women were significantly more likely to have stage III disease [RFD (95% CI): 12.2% (3.6%, 20.8%)] and to receive more aggressive treatment compared to nulliparous women. After adjustment for age, race and standard clinical tumor characteristics, recently postpartum women were significantly less likely to have delayed treatment initiation [RFD (95% CI): -11.2% (-21.4%, -1.0%)] and prolonged treatment duration [RFD (95% CI): -17.5% (-28.0%, -7.1%)], and were more likely to have mastectomy [RFD (95% CI): 14.9% (4.8%, 25.0%)] compared to nulliparous. Similarly, younger women (<40 years of age) were significantly less likely to experience prolonged treatment duration [RFD (95% CI): -5.6% (11.1%, -0.0%)] and more likely to undergo mastectomy [RFD (95% CI): 10.6% (5.2%, 16.0%)] compared to older women (≥40 years of age). ConclusionThese results suggest that recently postpartum and younger women often received prompt and aggressive breast cancer treatment. Higher mortality and recurrence among recently pregnant women are unlikely to be related to under-treatment.

Cancer ◽  
2019 ◽  
Vol 125 (22) ◽  
pp. 3985-3992
Author(s):  
Katherine E. Reeder‐Hayes ◽  
Sophie E. Mayer ◽  
Andrew F. Olshan ◽  
Stephanie B. Wheeler ◽  
Lisa A. Carey ◽  
...  

2015 ◽  
Vol 33 (28_suppl) ◽  
pp. 74-74
Author(s):  
Donatus U. Ekwueme ◽  
Benjamin T. Allaire ◽  
Gery Guy ◽  
Sarah Arnold ◽  
Justin G Trogdon

74 Background: Breast cancer is the most common malignant tumor among women in the United States, accounting for about 30% of incident cancers. It is one of the most costly medical conditions to treat. Younger women aged 18-44 years account for 11% of new cases. These women tend to experience more aggressive types of breast cancer, requiring intensive and expensive treatment. In recent years, a few studies have examined the costs of breast cancer treatment in a Medicaid population at the state level. However, no study has estimated medical costs for breast cancer treatment at the national level for women aged 19-44 years enrolled in Medicaid. Methods: A sample of 5,542 younger women aged 19-44 years, fee-for-service Medicaid enrollees, and diagnosed with breast cancer in 2007 were compared with 4.3 million women aged 19-44 years, fee-for-service Medicaid enrollees, but without breast cancer. The study used linear and nonlinear regression methods to estimate treatment costs for younger women with breast cancer compared with those without breast cancer. Individual medical costs were estimated by race/ethnicity and by type of services. All medical treatment costs were adjusted to 2010 dollars. Results: The estimated annual direct medical costs for breast cancer treatment among younger women enrolled in Medicaid ranged from nearly $25,000 to $42,000 per woman. Non-Hispanic black women had the highest annual total medical costs, followed by Hispanic women, while non-Hispanic women of other race had the lowest. The cost estimates ranged from $14,600 to $18,800 for outpatient service, $4,600 to $5,700 for inpatient service, and $3,500 to $4,800 for prescription drugs. Conclusions: The cost estimates demonstrate the substantial medical costs associated with breast cancer treatment for younger Medicaid beneficiaries. As the Medicaid program continues to evolve, the treatment cost estimates could serve as important inputs in decision-making regarding planning for treatment of invasive breast cancer in this population.


2015 ◽  
Vol 11 (2) ◽  
pp. e144-e153 ◽  
Author(s):  
Helen M. Parsons ◽  
Kate I. Lathrop ◽  
Susanne Schmidt ◽  
Marcela Mazo-Canola ◽  
Jessica Trevino-Jones ◽  
...  

The authors' findings suggest that in majority minority communities with large cancer centers, racial/ethnic disparities in times to biopsy and treatment initiation can be reduced.


2019 ◽  
Vol 10 (1) ◽  
pp. 122-125
Author(s):  
Melissa Arneil ◽  
Debra Anderson ◽  
Kimberly Alexander ◽  
Alexandra McCarthy

ObjectivesStudies indicate women aged 25–49 years previously treated for cancer report cognitive alterations. Good evidence indicates physical activity can be beneficial after cancer and might additionally benefit cognitive function. This short report presents data from a substudy of the Younger Women’s Wellness after Cancer Program (YWWACP), which explored cognitive alterations and investigated potential associations between physical activity and cognitive function in participants in the YWWACP. The primary aim of this substudy was to determine in younger women previously treated for breast cancer (1) whether subjectively reported cognitive function changed over time and (2) if physical activity is associated with subjectively reported cognitive function, and if time had an impact on this.MethodsAll participants had completed breast cancer treatment. Data were collected at baseline (n=41) and at 12 weeks. Measures assessed demographics, self-reported physical activity, cognitive function, sleep quality, stress, anxiety and depression using validated and reliable, subjectively reported instruments.ResultsCognitive function and physical activity scores increased across the time points, with cognitive function revealing a statistically significant increase over time (p=0.004). Statistical testing revealed that physical activity was not correlated with cognitive function and that change in physical activity was not correlated with change in cognitive function.ConclusionThese data provide early evidence that cognitive function and physical activity improved over time in this sample. However, interpretations of a correlation between physical activity and cognitive function should be made with caution, and future research would benefit from larger samples.


1999 ◽  
Vol 5 (3) ◽  
pp. 156-161 ◽  
Author(s):  
Penny Perkins ◽  
Catherine D. Cooksley ◽  
S. Eva Singletary ◽  
James D. Cox

Sign in / Sign up

Export Citation Format

Share Document